Premium
Use of imatinib mesylate in a cat with gastrointestinal stromal tumour
Author(s) -
Won Sungjun,
Kim Yongbaek,
Yoon Junghee
Publication year - 2019
Publication title -
veterinary record case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.165
H-Index - 4
ISSN - 2052-6121
DOI - 10.1136/vetreccr-2018-000714
Subject(s) - gist , medicine , imatinib , melena , imatinib mesylate , duodenum , gastroenterology , stromal tumor , stromal cell , pathology , myeloid leukemia
A two‐year‐old, Turkish Angora, neutered male cat was evaluated for acute onset of melena and anaemia. A mass was identified in the duodenum and was diagnosed as gastrointestinal stromal tumour (GIST) through immunohistochemistry. The cat developed suspected nephropathy after 12 months of imatinib treatment for GIST. Imatinib was discontinued, but the patient died after two months due to renal failure. GIST is a rare neoplasm in cats, and treatment with imatinib in feline GIST has not been previously reported.